Cargando…
Identification of RHEX as a novel biomarker related to progression and immunity of non-small cell lung carcinoma
BACKGROUND: The therapeutic response and prognosis of patients with non-small cell lung carcinoma (NSCLC) are widely related to immunity. To improve the prognosis of patients and provide reliable information to guide appropriate personalized treatment strategies, it is necessary to identify reliable...
Autores principales: | Xu, Tao, Dai, Tianyang, Zeng, Peiyuan, Song, Qi, He, Kaiming, Hu, Zhi, Li, Yuan, Li, Zhou |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797495/ https://www.ncbi.nlm.nih.gov/pubmed/35116680 http://dx.doi.org/10.21037/tcr-21-1316 |
Ejemplares similares
-
A novel immune-related gene signature predicts survival in esophageal squamous cell carcinoma
por: Xu, Tao, et al.
Publicado: (2021) -
RHEX in the mix of erythropoietin signaling molecules
por: Broxmeyer, Hal E.
Publicado: (2014) -
Optimization of the Oertli CataRhex 3(®) phacoemulsification machine
por: Stutz, Lance A, et al.
Publicado: (2019) -
Measurement of Phacoemulsification Vacuum Pressure in the Oertli CataRhex3
por: Peterson, John S, et al.
Publicado: (2022) -
Optimization of Phacoemulsification Tip Gauge on the Oertli CataRhex3 in an in vitro Setting
por: Peterson, John S, et al.
Publicado: (2022)